Showing results by publisher "Tantor Media" in Diabetes

Are you one of the millions dealing with diabetes? If so, you're probably all too familiar with the medical establishment badgering you to lose weight. But did you know evidence now shows that approaches focusing solely on weight loss are at best unhelpful and at worst, harmful? This groundbreaking guide outlines the principles of Intuitive Eating—an effective, evidence-based, anti-diet approach to nutrition—to help you manage your blood sugar levels without restriction.

The psychological impact of dealing with the stress of the daily management of both type 1 and type 2 diabetes can be frustrating and challenging. Yet this area is rarely discussed in medical settings despite the fact that the emotional context can undermine the person's ability to stay motivated in the essential self-care tasks that are vital for good health. Diabetes and Wellbeing presents a range of research-based psychological principles that have been demonstrated to positively impact emotional wellbeing.

Who is considered most at risk for diabetes, and why? In this thorough, engaging book, historian Arleen Tuchman examines and critiques how these questions have been answered by both the public and medical communities for over a century in the United States. Beginning in the late 19th century, Tuchman describes how at different times Jews, middle-class whites, American Indians, African Americans, and Hispanic Americans have been labeled most at risk for developing diabetes, and that such claims have reflected and perpetuated troubling assumptions about race, ethnicity, and class.

Decades of data cannot be ignored: African-American adults are far more likely to develop Type 2 diabetes than white adults. In a rousing indictment of the idea that notions of biological race should drive scientific inquiry, Sweetness in the Blood provides an ethnographic picture of biotechnology's framings of Type 2 diabetes risk and race and, importantly, offers a critical examination of the assumptions behind the recruitment of African American and African-descent populations for Type 2 diabetes research.

Bradwel reminds us that the centenary of this apparent "wonder drug" should be no cause for celebration. Insulin often remains inaccessible to those who need it most: elusive prescriptions, uneven availability and sky-high prices result in rationing and desperate do-it-yourself research and development. In the face of bootstraps rhetoric and "Pharma Bro" capitalists, patients across the world are left to fend for themselves. There is a long way to go in the twenty-first century until insulin truly fulfills the extraordinary promises made by its discovery.